About Us

Coulter Partners is a global search specialist focused exclusively on life sciences. The firm is held in the highest regard as trusted adviser to the sector on senior leadership roles in the American, U.K. and European Markets.

They have a combined expertise gained over 25 years in the industry, concentrated in the largest dedicated Life Sciences team in North America and Europe. 75 consultants work together as a single global P&L from 10 offices; 5 of these are in the US and 5 in Europe.

The firm’s approach is to hire and develop exceptional multi-skilled sector analysts with PhDs, MBAs, deep industry knowledge and an outstanding track record of search at Executive and Board level. Its team culture and personal reward system are founded on commitment to the highest standards of client and candidate service.

Their mission is to impact the industry’s ability to deliver advances in diagnosis, prevention, treatment and management of disease. They do this by bringing the world’s best talent to a broad spectrum of global clients; from multinationals, to small and midcap businesses, as well as to the global investor community, building their own teams and the boards and executive leadership of their portfolio investments.

Find a Recruiter

17

At the heart of everything they do Coulter Partners is an exceptional team of talented individuals. Multi-disciplined, passionate and committed to being the best, they have PhDs, MBAs and speak many languages. Every challenge is approached with a blend of innovative thinking and best-in-class search methodology. There are no barriers to sharing information and everyone is rewarded for quality delivery. Exchanging knowledge, experience and data brings mutual support. Success follows naturally.

Solutions And Expertise

Coulter Partners is a global search specialist focused exclusively on life sciences. The firm is held in the highest regard as trusted adviser to the sector on senior leadership roles in the American, U.K. and European Markets.

Solutions
  • Executive Search
Industries
Functions
  • CEO/President
  • Finance/Accounting
  • Human Resources
  • Marketing & Sales

News Briefings

Coulter Partners Opens in Paris, Expands Staff

Life sciences-focused executive search firm Coulter Partners has continued its recent growth with the opening of new office in Paris and 14 new appointments worldwide. All of this follows an extremely successful year which saw the firm’s revenues increase by 31 percent, making Coulter one of the fastest growing search firms this past year. “Another remarkable

Coulter Partners Recruits CEO for ArunA Bio

Persistent talent shortages and the need to develop and retain employees with critical business and technology skill-sets will continue to challenge global life sciences companies for the foreseeable future, according to Deloitte’s global sector outlook on life sciences. Navigating this new world of work requires a dramatic change in strategies for leadership, talent and human resources.

Slone Partners Places Chief Medical Officer at Goldfinch Bio

Executive search firm Slone Partners recently placed Frank Czerwiec as chief medical officer at Goldfinch Bio, a Cambridge, MA-based biotechnology company focused on discovering and developing precision medicines for the treatment of genetically-driven kidney diseases. “Goldfinch Bio is the leading life sciences and precision medicine company working passionately on kidney diseases which now affect over 800 million people

Coulter Partners Finds Chief Commercial Officer for Nanoform

Global executive search firm Coulter Partners has placed Christian Jones as chief commercial officer of Helsinki-based drug particle engineering and nanotechnology company Nanoform. Client partner Eskil Westh led the assignment. The appointment comes at a pivotal time in Nanoform’s growth, having recently completed a EUR 7 million funding round for investment in its technology and talent hiring. The

Press Releases

Coulter Partners Secures Vice President of Finance for Pivot Bio

LONDON, U.K., April 2019 – Coulter Partners has partnered again with Pivot Bio, an agriculture technology company based in Silicon Valley, to secure the appointment of Christa Peren as Vice President of Finance. Christa Peren joined Pivot Bio as VP-Finance in February 2019, bringing more than 25 years of business finance experience to the role.

Coulter Partners Secures new Country Manager for AniCura in DACH

LONDON, U.K., February 2019 – Coulter Partners was delighted to partner with international veterinary care provider, AniCura, to secure the appointment of Carla Naumann as the new Country Manager in Germany, Austria & Switzerland (DACH). Carla has some 20 years’ experience of various managerial roles within the healthcare sector in Germany and abroad. The recruitment

Coulter Partners Secures Chief of Business Operations for Nanoform

LONDON, U.K., January 2019 – Coulter Partners was very pleased to partner once again with innovative drug enabling nanotechnology company, Nanoform to secure the appointment of Dr. Gonçalo Rebelo de Andrade as Chief of Business Operations. The newly created role will significantly strengthen Nanoform’s commercial organization and continue its rapid growth through international sales. The

Coulter Partners secures Vice President, Corporate Development & Strategy for Zumutor Biologics

LONDON, U.K., – Coulter Partners was delighted to partner with Zumutor Biologics, a leading Immuno-Oncology Company in the targeted NK cell therapeutics space, to secure the appointment of Ramon Valencia as Vice President, Corporate Development and Strategy. Ramon will help build on Zumutor’s key successes that include proprietary antibody discovery platforms and a compelling pipeline of

Coulter Partners secures Chief Executive Officer for Biogazelle

LONDON, U.K., – Coulter Partners was very pleased to partner with Biogazelle, specialists in liquid biopsies and non-coding RNA, to secure the appointment of Armin Winands as its new Chief Executive Officer. He follows co-founder Jan Hellemans, who will take on the role of CTO after 10 years as CEO. The appointment of Armin Winands is